Table 2.
Poisson Regression Analysis Results. Female patients aged 45–54 with Private insurance and a diagnosis code other than the top 40 non-COVID diagnosis categories represent the reference group.
| Characteristic | Estimate | % Change | 95% CI | P-value | |
|---|---|---|---|---|---|
| Year 2020 | -0.43 | -35% | -39% to -31% | <0.01 | |
| Insurance Coverage | |||||
| Private | (reference) | ||||
| Medicare | -0.10 | -10% | -13% to -6% | <0.01 | |
| Medicaid | 0.01 | 2% | -3% to 7% | 0.56 | |
| Self Pay | 0.30 | 36% | 21% to 52% | <0.01 | |
| Age Group | |||||
| 0-2 | -0.46 | -37% | -50% to -20% | <0.01 | |
| 3-14 | -0.32 | -27% | -37% to -16% | <0.01 | |
| 15-24 | 0.05 | 5% | -4% to 15% | 0.24 | |
| 25-34 | 0.00 | 0% | -7% to 7% | 0.92 | |
| 35-44 | 0.04 | 4% | -3% to 12% | 0.24 | |
| 45-54 | (reference) | ||||
| 55-64 | 0.04 | 4% | -2% to 10% | 0.20 | |
| 65-74 | 0.01 | 1% | -5% to 7% | 0.85 | |
| 75-84 | -0.04 | -4% | -10% to 2% | 0.19 | |
| 85+ | -0.08 | -8% | -13% to -2% | 0.01 | |
| Gender | |||||
| Female | (reference) | ||||
| Male | 0.08 | 8% | 5% to 12% | <0.01 | |
| Diagnosis | |||||
| All other Dx | (reference) | ||||
| Chest Pain | 0.04 | 4% | -4% to 12% | 0.36 | |
| Pneumonia | -0.02 | -2% | -10% to 7% | 0.68 | |
| Heart Failure | -0.17 | -16% | -24% to -8% | <0.01 | |
| Alcohol Related | 0.15 | 16% | 6% to 28% | <0.01 | |
| Depression | -0.07 | -7% | -15% to 3% | 0.17 | |
| Urinary Tract Infection | 0.05 | 6% | -5% to 17% | 0.30 | |
| Fluid/Electrolyte Disorders | 0.16 | 18% | 6% to 31% | <0.01 | |
| Schizophrenia | 0.07 | 8% | -3% to 20% | 0.16 | |
| Cardiac Dysrhythmias | -0.01 | -1% | -11% to 10% | 0.85 | |
| COPD | -0.40 | -33% | -41% to -24% | <0.01 | |
| Skin/Subcutaneous Infections | -0.08 | -7% | -18% to 4% | 0.20 | |
| Self-harm/Suicidal Intent | 0.35 | 42% | 27% to 58% | <0.01 | |
| Septicemia | 0.01 | 1% | -10% to 14% | 0.83 | |
| Gastrointestinal Hemorrhage | 0.22 | 24% | 11% to 40% | <0.01 | |
| Abdominal Pain | 0.16 | 17% | 4% to 32% | 0.01 | |
| Renal Failure | 0.10 | 11% | -2% to 25% | 0.09 | |
| Syncope | -0.03 | -2% | -15% to 11% | 0.71 | |
| Diabetes Mellitus | 0.22 | 25% | 10% to 42% | <0.01 | |
| Nervous System | 0.16 | 18% | 3% to 35% | 0.02 | |
| Respiratory Symptoms | 0.45 | 56% | 36% to 79% | <0.01 | |
| Superficial Injury | -0.10 | -10% | -22% to 4% | 0.15 | |
| Cerebral Infarction | 0.03 | 3% | -11% to 20% | 0.69 | |
| Intestinal Obstruction | 0.21 | 23% | 5% to 43% | <0.01 | |
| Biliary Tract Disease | 0.14 | 15% | -2% to 34% | 0.08 | |
| Fracture of Hip | 0.46 | 59% | 36% to 86% | <0.01 | |
| Pancreatic Disorders | 0.23 | 26% | 8% to 48% | <0.01 | |
| Acute Myocardial Infarction | 0.31 | 37% | 16% to 61% | <0.01 | |
| Appendicitis | 0.13 | 13% | -4% to 34% | 0.13 | |
| Bipolar Disorder | 0.16 | 17% | -1% to 38% | 0.06 | |
| Sensation/Perception Symptoms | 0.02 | 2% | -14% to 22% | 0.79 | |
| Respiratory Failure | 0.49 | 63% | 38% to 92% | <0.01 | |
| Epilepsy/Convulsions | 0.07 | 7% | -10% to 27% | 0.45 | |
| Aplastic Anemia | 0.19 | 21% | 2% to 45% | 0.03 | |
| Chronic Kidney Disease | 0.08 | 8% | -10% to 29% | 0.39 | |
| Fracture of Leg | 0.29 | 34% | 12% to 60% | <0.01 | |
| TBI/Concussion | 0.60 | 82% | 52% to 118% | <0.01 | |
| Transient Cerebral Ischemia | 0.15 | 17% | -2% to 39% | 0.09 | |
| Fracture of Torso | 0.14 | 15% | -4% to 38% | 0.13 | |
| Malaise/Fatigue | 0.14 | 15% | -4% to 39% | 0.13 | |
| Asthma | 0.12 | 13% | -7% to 36% | 0.22 | |